Anne Li September 16th, 2017 anne2001.li@gmail.com
In selected populations of patients with advanced cancer, universal sequencing of germline and tumor DNA for a broad panel of cancer-related genes may detect more potentially clinically significant heritable mutations than a targeted approach based on current clinical guidelines. It is not known if this will result in improved outcomes.
See original article at: https://jamanetwork.com/journals/jama/article-abstract/2652651
Post a comment